Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, Patel JK, Keefe RS, Stroup TS, Lieberman JA.

Schizophr Res. 2005 Dec 1;80(1):9-18. Epub 2005 Aug 24.

PMID:
16125372
[PubMed - indexed for MEDLINE]
2.

Antipsychotics and metabolics in the post-CATIE era.

Meyer JM.

Curr Top Behav Neurosci. 2010;4:23-42. Review.

PMID:
21312396
[PubMed - indexed for MEDLINE]
3.
4.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
5.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
6.

Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.

Newcomer JW.

J Clin Psychiatry. 2007;68 Suppl 1:20-7. Review.

PMID:
17286524
[PubMed - indexed for MEDLINE]
7.

The metabolic syndrome and schizophrenia.

Meyer JM, Stahl SM.

Acta Psychiatr Scand. 2009 Jan;119(1):4-14. doi: 10.1111/j.1600-0447.2008.01317.x. Review.

PMID:
19133915
[PubMed - indexed for MEDLINE]
8.

[Comorbidity of metabolic syndrome, diabetes and schizophrenia: theoretical and practical considerations].

Réthelyi J, Sawalhe AD.

Orv Hetil. 2011 Mar 27;152(13):505-11. doi: 10.1556/OH.2011.29079. Review. Hungarian.

PMID:
21398211
[PubMed - indexed for MEDLINE]
Free Article
9.

Physical health in schizophrenia: a challenge for antipsychotic therapy.

Heald A.

Eur Psychiatry. 2010 Jun;25 Suppl 2:S6-11. doi: 10.1016/S0924-9338(10)71700-4. Review.

PMID:
20620888
[PubMed - indexed for MEDLINE]
10.

The need for routine physical health care in schizophrenia.

Montejo AL.

Eur Psychiatry. 2010 Jun;25 Suppl 2:S3-5. doi: 10.1016/S0924-9338(10)71699-0. Review.

PMID:
20620884
[PubMed - indexed for MEDLINE]
11.

[Metabolic syndrome in patients with schizophrenia and antipsychotic treatment].

Aguilar E, Coronas R, Caixàs A.

Med Clin (Barc). 2012 Nov 17;139(12):542-6. doi: 10.1016/j.medcli.2012.05.028. Epub 2012 Jul 28. Review. Spanish.

PMID:
22841467
[PubMed - indexed for MEDLINE]
12.

[Metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake].

Bou Khalil R.

Presse Med. 2012 May;41(5):e238-43. doi: 10.1016/j.lpm.2011.10.013. Epub 2011 Dec 6. Review. French.

PMID:
22154487
[PubMed - indexed for MEDLINE]
13.

[Epidemiology of schizophrenia].

Nonaka S, Ichinose H, Kinoshita H, Nakane H.

Nihon Rinsho. 2013 Apr;71(4):583-8. Review. Japanese.

PMID:
23678583
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk